Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDunelm Regulatory News (DNLM)

Share Price Information for Dunelm (DNLM)

Share Price is delayed by 15 minutes
Get Live Data
764.00    -4.00 (-0.52%)
Bid:
763.00
Ask:
764.50
Spread: 1.50 (0.197%)
Market Cap: £1.54b
DNLM Live PriceLast checked at - London Stock Exchange

Intraday Dunelm Share Chart

Director/PDMR Shareholding

31 Oct 2025 09:52

RNS Number : 7036F
Dunelm Group plc
31 October 2025
 

31 October 2025

DUNELM GROUP PLC

NOTIFICATION OF TRANSACTIONS OF DIRECTORS/PERSONS EXERCISING MANAGERIAL RESPONSIBILITY AND CONNECTED PERSONS

On 30 October 2025 share incentive awards were granted over ordinary shares of one pence each in the Company, in the form of a nil cost option under the Dunelm Group 2014 Long Term Incentive Plan to the following persons discharging managerial responsibilities:

PDMR

Number of shares under award

Clo Moriarty

146,981

Karen Witts

86,390

Luisa Wright

24,618

James Cooper

3,677

 

In the case of Clo Moriarty, Karen Witts and Luisa Wright, the options may be exercised on or after 30 October 2028, subject to the satisfaction of performance conditions over the three financial periods commencing on 29 June 2025. These performance conditions are detailed in the Company's FY25 Annual Report. In the case of James Cooper, the options may be exercised on or after 30 October 2027, subject to the satisfaction of performance conditions.

On exercise, Clo Moriarty and Karen Witts have each committed to retain (after sale to cover tax and national insurance liability on exercise), at least two thirds of these for the duration of employment. In addition, shareholding requirements apply for the duration of employment and for two years from termination of employment, as set out in the 2023 Remuneration Policy ("2023 Policy") approved on 16 November 2023.

In line with its 2023 Policy, the Remuneration Committee can apply malus or clawback to the awards and has discretion to vary formulaic outturns where this does not reflect underlying performance or is inappropriate in the context of unexpected or unforeseen circumstances.

 

For further information please contact: 

 

Dunelm Group plc

Luisa Wright/Simon Hockridge

 

 

InvestorRelations@dunelm.com

 

 

MHP Communications

 

 

Rachel Farrington/Charles Hirst

 

 

dunelm@mhpc.com

DUNELM GROUP PLC

NOTIFICATION OF TRANSACTIONS OF PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES

 

1

 

Details of the person(s) discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

1. Clodagh Moriarty

2. Karen Witts

3. Luisa Wright

4. James Cooper

2

 

Reason for the notification

 

a)

 

Position/status

 

1. Chief Executive

2. Chief Financial Officer

3. PDMR

4. PDMR

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Dunelm Group plc

b)

 

LEI

 

213800WCOWEI3T5DUV19

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of one pence each 

 

 

ISINGB00BICQ739

 

b)

 

Nature of the transaction

 

 

Grant of nil-cost share options conditional on future performance in accordance with the Company's long term incentive plan

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

1. £Nil

2. £Nil

3. £Nil

4. £Nil

 

146,981

86,390

24,618

3,677

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 Single transaction for each individual

 

 

 

e)

 

Date of the transaction

 

 

2025.10.30

f)

 

Place of the transaction

 

 

Outside a trading venue

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHPKDBQCBDKFKN
Date   Source Headline
9th Sep 20257:00 amRNSPreliminary Results
31st Jul 20257:00 amRNSTotal Voting Rights
17th Jul 20257:00 amRNSFourth quarter and full year trading update
14th Jul 202512:30 pmRNSDirector Declaration
7th Jul 202512:30 pmRNSAppointment of CEO
1st Jul 20257:00 amRNSTotal Voting Rights
17th Jun 20257:00 amRNSDirector/PDMR Shareholding
30th May 20257:00 amRNSTotal Voting Rights
8th May 20257:00 amRNSDirector/PDMR Shareholding
6th May 20257:00 amRNSAppointment of Katharine Poulter as NED
30th Apr 20257:00 amRNSTotal Voting Rights
17th Apr 20257:00 amRNSThird quarter trading update
14th Apr 20257:00 amRNSBlock Listing Six Monthly Return
1st Apr 20259:50 amRNSTotal Voting Rights
17th Mar 20257:00 amRNSTransaction in Own Shares
14th Mar 20257:00 amRNSTransaction in Own Shares
13th Mar 20257:00 amRNSTransaction in Own Shares
12th Mar 20257:00 amRNSTransaction in Own Shares
11th Mar 20257:00 amRNSTransaction in Own Shares
10th Mar 20257:00 amRNSTransaction in Own Shares
7th Mar 20257:00 amRNSTransaction in Own Shares
6th Mar 20257:00 amRNSTransaction in Own Shares
5th Mar 20257:00 amRNSTransaction in Own Shares
4th Mar 20257:00 amRNSTransaction in Own Shares
3rd Mar 20257:00 amRNSTotal Voting Rights
3rd Mar 20257:00 amRNSTransaction in Own Shares
28th Feb 20257:00 amRNSTransaction in Own Shares
27th Feb 20257:00 amRNSTransaction in Own Shares
26th Feb 20257:00 amRNSTransaction in Own Shares
25th Feb 20257:00 amRNSTransaction in Own Shares
24th Feb 20257:00 amRNSTransaction in Own Shares
21st Feb 20257:00 amRNSTransaction in Own Shares
20th Feb 20257:00 amRNSTransaction in Own Shares
19th Feb 20251:00 pmRNSPurchases of Shares During Open Periods
11th Feb 20257:00 amRNSCEO succession
11th Feb 20257:00 amRNSInterim Results
31st Jan 20257:00 amRNSTotal Voting Rights
16th Jan 20257:00 amRNSSecond quarter and first half trading update
31st Dec 20247:00 amRNSTotal Voting Rights
18th Dec 20247:00 amRNSDirector Declaration
29th Nov 202411:00 amRNSTotal Voting Rights
21st Nov 20243:18 pmRNSResults of AGM
20th Nov 20247:00 amRNS-RAcquisition of Home Focus
1st Nov 20241:00 pmRNSDirector/PDMR Shareholding
31st Oct 202411:00 amRNSTotal Voting Rights
30th Oct 20243:00 pmRNSDirector/PDMR Shareholding
24th Oct 20247:00 amRNSFirst quarter trading update
18th Oct 20244:00 pmRNSSale of Shares by Concert Party and AGM Notice
14th Oct 20247:00 amRNSDirector Declaration
10th Oct 202410:01 amRNSAnnual report and accounts and Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.